Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

BRL-48482 has potential for reducing cardiovascular risk in NIDDM

June 12, 1997

Phase III results for AY-4166

June 12, 1997

Pioglitazone improves insulin resistance in NIDDM

June 12, 1997

New preclinical studies on JTT-501

June 12, 1997

Clinical results in NIDDM reported for troglitazone

June 12, 1997

Efficacy of pioglitazone demonstrated in NIDDM patients

June 11, 1997

Miglitol tested in specific population subgroups

June 11, 1997

Clinical results reported for Novo Nordisk insulinotropic agent

June 11, 1997

NN-304, a long-acting insulin analogue in preclinical testing

June 10, 1997

Skelid introduced in the U.S.

June 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...